Chapter one · the words
Telehealth is the way care reaches you. It is not a type of medicine, a quality seal or a promise that every offer is sound.
Peptide means a short chain of the building blocks found in proteins. Insulin is one example; so is the hormone used in some weight-loss shots.
Peptide is a chemistry word, not a stamp of safety or legal status. It covers many different substances, so the label by itself says nothing about how a product acts in the body.
Telehealth describes a visit at a distance. It does not tell you what product is offered or whether that product is approved.
Compounding means a pharmacist or doctor makes up a medicine for a single patient rather than handing over a factory-made product from a drug company.
The Food and Drug Administration reviews a specific product, not a broad idea such as “men's wellness” or “peptide therapy.” Approval alone does not decide whether that product fits a particular person.
As of September 2026, compounding can be a lawful part of care, but a compounded medicine is not FDA-approved.
Before a compounded medicine goes on sale, the FDA does not check its safety, whether it does its job, or the quality of its manufacture.
“FDA registered” only means the business has put its name on an FDA list, which it chose to do. It is not the FDA approving the business or any medicine it makes.
In FDA warning letters, as of September 2026, the agency says a chemical sold for people to use is not a legal treatment, even when its label says “research use only.” The label does not change what the product is.
The screen is only the doorway. The important parts are the assessment, the person responsible for it and the plan after it.
The service asks where you are during the visit because state rules apply there.
The intake gathers your goals, symptoms, medicines and health history, with room for follow-up questions.
A named prescriber with a licence, such as a doctor, reads your answers and asks more. That person decides whether a screen visit can give you the same care as a visit in a room, and sends you to be seen in person if it cannot.
The result may be a plan, a test, an in-person referral or no prescription.
The service explains how questions, results and problems are handled after the visit.